Search Results

A7 - Administration of Enteral Feed Product (P48)

Administration of Enteral Feed Product

Locked Box Pathway (G335)

Locked Box Pathway

Disclosure Ref 202534 - Spend on Sodium Hyaluronate eye drop.pdf

Freedom of information disclosure regarding spend on Sodium Hyaluronate eye drop

Disclosure Ref 202504 - Vials used & patients treated 2024 .pdf

Freedom of Information disclosure ref 202504 relating to vials used and number of patients treated

Disclosure Ref 2025126 - Amputation Surgeries since 2017.pdf

FOI Disclosure Ref 2025126 regarding amputation Surgeries since 2017

Disclosure Ref 2025159 - Eating disorder service.pdf

Disclosure Ref 2025159 regarding Eating disorder service

HRP19 Management of Change Manager's Guide - Appendix 11 Appeal Hearing Format and Process.docx

Disclosure Ref 2025195 - Cancer pathway referrals .pdf

Freedom of information request reference 2025195 relating to Cancer pathway referrals in the last 5 years

Disclosure Ref 2025166 - Allegations of antisemitism, islamophobia and racism against Palestinians and or Arabs.pdf

FOI disclosure ref 2025166 relating to number of persons who work or have worked at DCHS who have been the subject to complaints on the basis of allegations of antisemitism, islamophobia and racism against Palestinians and/or Arabs since 7 October 2023

Drug Management of Violence and Aggression and Rapid Tranquilisation Policy (P114)

The aim of this policy is to support practitioner’s decision making, when considering or using medication by the parenteral route, when the use of oral medication is not possible or appropriate and urgent sedation with medication is required. NICE Guidance NG10 (2015)